LFTD Partners Inc. (LSFP) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
LFTD Partners Inc. (LSFP) trades at $3.92. LFTD Partners Inc. focuses on acquiring and operating companies in the hemp-derived products, e-liquid, and alternative products sectors. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for LSFP: LSFP does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates LSFP against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
Not enough scored data yet to form a council read on LSFP.
How is this calculated? →LFTD Partners Inc. (LSFP) Healthcare & Pipeline Overview
LFTD Partners Inc. operates within the specialty and generic drug manufacturing sector, focusing on hemp-derived products, e-liquids, and alternative products. With a negative P/E ratio and a focus on acquisitions, the company aims to establish a diverse brand portfolio in the evolving consumer market, while navigating the challenges of profitability and market competition.
What Is the Investment Thesis for LSFP?
Investing in LFTD Partners Inc. presents a high-risk, high-reward scenario. The company's focus on acquiring brands in the hemp-derived and alternative product sectors offers potential for growth, but profitability remains a key concern, given the negative P/E ratio of -32.31 and a negative profit margin of -2.7%. The gross margin of 34.0% indicates some pricing power, but operational efficiency needs improvement. The company's beta of -0.95 suggests a potential inverse correlation with the market, which could offer diversification benefits. Key catalysts include successful integration of acquired brands and expansion into new product categories. However, regulatory risks and intense competition pose significant challenges. Investors should closely monitor the company's ability to achieve profitability and manage its growth effectively.
Based on FMP financials and quantitative analysis
LSFP Key Highlights
Gross Margin of 34.0% indicates the company's ability to generate revenue after accounting for the cost of goods sold.
- Negative P/E Ratio of -32.31 reflects the company's current lack of profitability.
- Profit Margin of -2.7% highlights the challenges LFTD Partners faces in converting revenue into profit.
- Beta of -0.95 suggests a potential inverse correlation with the market, offering potential diversification benefits.
- Focus on acquiring companies in the hemp-derived and alternative product sectors, positioning it within a growing market.
Who Are LSFP's Competitors?
LSFP is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BIOGF Biocartis Group N.V. | $0.66 | -85.33% | $65.4M | 52 |
| BSTG Biostage, Inc. | $4.03 | +0.75% | $57.8M | 44 |
| CSWYY China Shineway Pharmaceutical Group Limited | $19.25 | +0.00% | $36.4M | 43 |
| EEOIF Elegance Optical International Holdings Limited | $0.07 | +0.00% | $63.4M | 46 |
| EOFBY Ecofibre Limited | $0.84 | +0.00% | $73.7M | 40 |
| ZTS Zoetis Inc. | $75.44 | -1.62% | $31.6B | 85 |
| ITCI ITCI | $131.87 | +0.00% | $14.1B | 63 |
| ESALF Eisai Co., Ltd. | $29.90 | +0.00% | $8.44B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are LSFP's Key Strengths?
Focus on high-growth markets (hemp-derived products, e-liquids).
- Established brands through acquisitions.
- Distribution network in the United States.
What Are LSFP's Weaknesses?
Negative profitability (negative P/E and profit margin).
- Reliance on acquisitions for growth.
- Limited financial resources.
What Could Drive LSFP Stock Higher?
Potential acquisitions of new brands in the hemp-derived and alternative product sectors.
- Expansion of existing brands into new product categories.
- Development of strategic partnerships and distribution agreements.
- Positive regulatory developments in the hemp-derived and alternative product markets.
- Increased consumer demand for hemp-derived and alternative products.
What Are the Key Risks for LSFP?
Negative return on equity (-54.9%) — the business is not currently generating profit on shareholder capital.
- Evolving regulatory landscape for hemp-derived and alternative products.
- Intense competition from established players and emerging brands.
- Negative consumer perception of hemp-derived and alternative products.
- Dependence on acquisitions for growth.
- Limited access to capital.
What Are the Growth Opportunities for LSFP?
- Expansion into New Product Categories: LFTD Partners can leverage its existing infrastructure and brand portfolio to expand into adjacent product categories within the hemp-derived and alternative product sectors. This includes exploring new CBD-infused products, innovative nicotine alternatives, and emerging cannabinoid compounds. Timeline: Ongoing.
- Strategic Acquisitions: LFTD Partners can continue to pursue strategic acquisitions of complementary brands and businesses within the hemp-derived and alternative product sectors. This allows the company to expand its market share, diversify its product offerings, and gain access to new distribution channels. Successful integration of acquired businesses is crucial for realizing synergies and driving long-term growth. Timeline: Ongoing.
- Geographic Expansion: LFTD Partners can expand its geographic reach by entering new markets within the United States and internationally. This includes targeting states with favorable regulatory environments for hemp-derived products and exploring opportunities in emerging markets with growing demand for alternative nicotine products. Geographic expansion can significantly increase the company's revenue potential. Timeline: 1-3 years.
- Development of Proprietary Brands: LFTD Partners can invest in the development of its own proprietary brands within the hemp-derived and alternative product sectors. This allows the company to differentiate itself from competitors, build brand loyalty, and capture higher margins. Successful brand development requires strong marketing, product innovation, and a deep understanding of consumer preferences. Timeline: 2-5 years.
- Partnerships and Distribution Agreements: LFTD Partners can establish partnerships and distribution agreements with retailers, distributors, and other industry players to expand its reach and increase its sales volume. This includes targeting both online and brick-and-mortar channels. Strategic partnerships can provide access to new customers and markets, accelerating the company's growth. Timeline: Ongoing.
What Are LSFP's Competitive Advantages?
- Brand portfolio in the growing hemp-derived and alternative product sectors.
- Established distribution channels through acquired companies.
- Expertise in acquiring and integrating businesses in the specialty drug market.
What Does LSFP Do?
LFTD Partners Inc., formerly known as Acquired Sales Corp., was incorporated in 1986 and rebranded in September 2021 to reflect its strategic shift towards acquiring and operating businesses in the hemp-derived products and alternative nicotine sectors. Headquartered in Jacksonville, Florida, the company focuses on manufacturing and selling branded hemp-derived products, e-liquid, disposable nicotine vapes, kratom, and kava products within the United States. LFTD Partners operates through its 50% interest in SmplyLifted LLC, which markets tobacco-free nicotine pouches under the FR3SH brand and offers CBD-infused beverages and products. The company's business model centers around acquiring and scaling brands in the alternative products space, targeting consumer preferences for novel and emerging product categories. LFTD Partners aims to capitalize on the growing demand for these products while navigating the regulatory complexities and competitive pressures inherent in these markets. The company's evolution reflects a strategic pivot to align with changing consumer trends and emerging market opportunities in the specialty drug and alternative products sectors.
What Products and Services Does LSFP Offer?
- Acquires companies that manufacture and sell branded hemp-derived products.
- Operates in the e-liquid and disposable nicotine vape market.
- Deals in kratom and kava products within the United States.
- Sells tobacco-free nicotine pouches under the brand name FR3SH through its interest in SmplyLifted LLC.
- Offers CBD-infused beverages and products.
- Focuses on building a portfolio of brands in the alternative products space.
How Does LSFP Make Money?
- Acquisition of existing brands in the hemp-derived and alternative product sectors.
- Manufacturing and distribution of acquired brands' products.
- Sales through various channels, including online and retail partnerships.
What Industry Does LSFP Operate In?
LFTD Partners operates in the evolving specialty and generic drug manufacturing sector, specifically targeting the hemp-derived products, e-liquid, and alternative nicotine markets. These markets are characterized by rapid growth, changing consumer preferences, and evolving regulatory landscapes. The competitive landscape includes both established players and emerging brands, creating a dynamic and challenging environment. LFTD Partners aims to differentiate itself through strategic acquisitions and brand development. The company's success depends on its ability to navigate the regulatory complexities, adapt to changing consumer trends, and effectively compete in these high-growth markets.
Who Are LSFP's Key Customers?
- Consumers of hemp-derived products, including CBD-infused beverages and products.
- Users of e-liquids and disposable nicotine vapes.
- Individuals seeking kratom and kava products.
Key Financial Metrics
Return on equity for LFTD Partners Inc. stands at -54.9%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is 42.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.26 indicates the company holds enough short-term assets to cover its near-term obligations.
Company Profile
LFTD Partners Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Jacksonville, US. LSFP has traded publicly since 2021.
Insider Activity
The most recent 9 insider filings for LFTD Partners Inc. break down as 0 sales and 9 purchases. On net that is roughly 1.0M shares acquired (about $71K) — insiders putting money in tends to read as conviction.
LSFP Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Focus on high-growth markets (hemp-derived products, e-liquids).
- Established brands through acquisitions.
- Distribution network in the United States.
- Upcoming: Potential acquisitions of new brands in the hemp-derived and alternative product sectors.
Bear Case
- Negative profitability (negative P/E and profit margin).
- Reliance on acquisitions for growth.
- Limited financial resources.
- Potential: Evolving regulatory landscape for hemp-derived and alternative products.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
LSFP Latest News
No recent news available for LSFP.
LSFP Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for LSFP.
Price Targets
Wall Street price target analysis for LSFP.
LSFP MoonshotScore
What does this score mean?
The MoonshotScore rates LSFP 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
LSFP OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that LFTD Partners Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Limited financial disclosure due to OTC Other tier status.
- Potential for lower liquidity and wider bid-ask spreads.
- Higher price volatility compared to stocks on major exchanges.
- Increased risk of fraud or manipulation.
- Limited regulatory oversight.
- Verify the company's financial statements and SEC filings (if available).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance and legal risks.
- Monitor the company's news and press releases for any red flags.
- Consult with a financial advisor before investing.
- Understand the risks associated with investing in OTC stocks.
- Company has been in operation since 1986.
- Focus on acquiring and operating businesses in the hemp-derived and alternative product sectors.
- Presence in the United States market.
LFTD Partners Inc. Healthcare Stock: Key Questions Answered
What does LFTD Partners Inc. do?
LFTD Partners Inc. focuses on acquiring and operating companies that manufacture and sell branded hemp-derived products, e-liquids, disposable nicotine vapes, kratom, and kava products in the United States. Through its 50% interest in SmplyLifted LLC, the company also sells tobacco-free nicotine pouches under the FR3SH brand and offers CBD-infused beverages and products.
What do analysts say about LSFP stock?
As of March 16, 2026, there is no readily available analyst consensus on LFTD Partners Inc. (LSFP) due to its OTC listing and limited coverage. The company's valuation metrics, such as the negative P/E ratio, reflect its current lack of profitability.
What are the main risks for LSFP?
The main risks for LFTD Partners Inc. include the evolving regulatory landscape for hemp-derived and alternative products, intense competition from established players and emerging brands, potential negative consumer perception of these products, dependence on acquisitions for growth, and limited access to capital.
What are the key factors to evaluate for LSFP?
Evaluate LSFP on fundamentals, analyst consensus, and risk factors. Investing in LFTD Partners Inc. presents a high-risk, high-reward scenario. Not financial advice.
How frequently does LSFP data refresh on this page?
LSFP's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven LSFP's recent stock price performance?
LFTD Partners Inc. (LSFP) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on high-growth markets (hemp-derived products, e-liquids). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider LSFP overvalued or undervalued right now?
LFTD Partners Inc. (LSFP) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research LSFP before investing?
Before investing in LFTD Partners Inc. (LSFP), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- OTC market data may be less reliable than major exchange data.
- AI analysis pending for LSFP.